FIELD: pharmaceuticals.
SUBSTANCE: invention relates to pharmaceutical industry and biotechnology, namely to means for delivery of an active agent comprising a liposomal suspension complex with a chitosan conjugate which is a compound of formula (C6O4H9NH2)m(C6O4H9NHX)n, wherein the substituent on the amino group X is a monomethoxy-PEG succinate, m and n are the number of units in the molecule, the m/n ratio being 6 to 19, and chitosan is used with a molecular weight of 15,000 to 120,000 Da, while liposomes are associated with the chitosan conjugate non-covalently.
EFFECT: invention provides improvement in stability of liposomal suspensions.
1 cl, 4 dwg
| Title | Year | Author | Number | 
|---|---|---|---|
| LIPOSOMAL SUSPENSIONS STABILISER | 2015 | 
 | RU2642786C2 | 
| LIPID-POLYMER SYSTEM FOR SIMULTANEOUS DELIVERY OF TWO ANTIBACTERIAL COMPOUNDS | 2023 | 
 | RU2838145C1 | 
| LIPOSOMAL COMPOSITIONS AND SOLID PERORAL MEDICINAL FORMS COMPRISING SUCH COMPOSITIONS | 2018 | 
 | RU2751192C2 | 
| LIPOSOMAL COMPOSITIONS USED FOR DRUG DELIVERY | 2015 | 
 | RU2757110C2 | 
| LIPOSOMAL COMPOSITIONS APPLICABLE FOR DRUG DELIVERY | 2005 | 
 | RU2574926C2 | 
| TRANSPULMONARY LIPOSOME FOR CONTROLLING DRUG DELIVERY | 2008 | 
 | RU2493874C2 | 
| LIPOSOME SUSPENSION STABILISER AND METHOD FOR PRODUCTION THEREOF | 2013 | 
 | RU2529179C1 | 
| DISPOSABLE SYSTEM FOR STERILE OBTAINING OF LIPIDS AND NUCLEIC ACIDS PARTICLES | 2012 | 
 | RU2642640C2 | 
| IMPROVED LIPOSOMES AND THEIR APPLICATION | 2008 | 
 | RU2482837C2 | 
| TARGETING AMINOACID LIPIDS | 2013 | 
 | RU2654210C2 | 
Authors
Dates
2018-10-10—Published
2017-09-08—Filed